CRCM (Centre de Ressources et de Compétences de la Mucoviscidose), Fondation Ildys, Roscoff, France.
Direction de la Recherche Clinique et de l'Innovation (DRCI), CHU de Brest, Brest, France & Centre d'Investigation Clinique, INSERM CIC 1412, CHU de Brest, Brest, France.
J Cyst Fibros. 2024 May;23(3):579-586. doi: 10.1016/j.jcf.2023.10.011. Epub 2023 Oct 29.
In cystic fibrosis (CF), coughing is associated with a risk of pelvic floor dysfunction. However, data on the prevalence of symptoms (stress urinary incontinence, bladder overactivity, dysuria, and faecal incontinence) are lacking in males and females with CF. The impact of incontinence on adherence to respiratory care has not been studied.
We conducted a multicentre study in adults with CF followed in the North-West French CF network. Urinary disorders and their severity were assessed using the Urinary Symptom Profile (USP) self-report questionnaire; the impact of urinary disorders on general quality of life was measured using the SF-Qualiveen questionnaire; faecal incontinence was assessed using the Wexner self-report questionnaire; and the CFQ-R14+ questionnaire was used to assess quality of life. A self-administered questionnaire developed for the study assessed the impact of symptoms on respiratory care.
Of the 178 people with CF included, 34 % reported stress urinary incontinence, with a large female predominance (63.5 % of females vs. 7.5 % of males), 65 % bladder overactivity (including 16 % urge incontinence) and 50 % faecal incontinence, also with a female predominance. Neither urinary nor faecal incontinence were related to the severity of the respiratory impairment (FEV1). Quality of life was particularly affected in women. Stress urinary Incontinence symptoms affected respiratory care in both sexes.
The prevalence of functional urinary and faecal disorders was high in adults with CF and impacted on quality of life and respiratory care. Therefore, multidisciplinary teams must have knowledge of symptoms, the diagnostic tools and management strategies to provide specific treatment.
在囊性纤维化(CF)中,咳嗽与盆底功能障碍的风险相关。然而,CF 男性和女性的症状(压力性尿失禁、膀胱过度活动症、排尿困难和粪便失禁)患病率数据尚缺乏。失禁对呼吸治疗依从性的影响尚未研究。
我们在法国西北部 CF 网络中进行了一项多中心研究,纳入成年 CF 患者。使用尿症状量表(USP)自我报告问卷评估尿障碍及其严重程度;使用 SF-Qualiveen 问卷评估尿障碍对一般生活质量的影响;使用 Wexner 自我报告问卷评估粪便失禁;使用 CFQ-R14+问卷评估生活质量。为研究开发的自我管理问卷评估了症状对呼吸治疗的影响。
在纳入的 178 名 CF 患者中,34%报告有压力性尿失禁,女性居多(女性占 63.5%,男性占 7.5%),65%有膀胱过度活动症(包括 16%的急迫性尿失禁),50%有粪便失禁,女性也居多。尿失禁和粪便失禁均与呼吸损害严重程度(FEV1)无关。生活质量尤其受到女性的影响。尿失禁症状影响两性的呼吸治疗。
CF 成人功能性尿和粪障碍的患病率较高,影响生活质量和呼吸治疗。因此,多学科团队必须了解症状、诊断工具和管理策略,以提供特定的治疗。